Dr.

Firshein Speaks on Ovarian Health and Natural Alternatives to Hormone

Replacement Therapy

Dr. Richard Firshein, world-renowned pioneer and leading expert in the fields of Integrative and
Preventative Medicine, will be speaking tonight at Maison Beljanski presents Healthy Tuesdays:
Ovarian Health. His presentation will focus on ovarian health and natural alternatives to Hormone
Replacement Therapy.

New York, NY, October 30, 2018 --(PR.com)-- Dr. Richard Firshein is a world-renowned pioneer and
leading expert in the fields of Integrative and Preventative Medicine. He provides unparalleled medical
care by performing a unique set of tests which combine comprehensive Allergy, DNA, Nutritional, Gut
Biome and Metabolic evaluations, and using them to design individualized treatment programs for each
of his patients. He is the founder and medical director of The Firshein Center for Integrative Medicine,
where his patients receive an exclusively curated and personalized medical experience. Known for his
compassionate and holistic approach, Dr. Firshein is the doctor patients come to when no else can figure
out what is wrong with them; and is noted for proactively approaching your health by thoroughly
evaluating your medical history to determine if specific risk factors are contributing to chronic illnesses.

Tonight, Dr. Firshein's talk will focus on the important factors surrounding ovarian health; and and also
highlight his success in treating his female patients before, during, and after menopause utilizing his
holistic and personalized approach. Additionally, Dr. Richard Firshein will provide natural alternatives
for Hormone Replacement Therapy; such as bioidentical hormones, natural supplements, and
compounded bioidentical hormones.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
Dr. Richard Firshein
Karina Ortiz-Johnson
212-860-0282
Contact via Email
http://www.firsheincenter.com

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/768764

News Image:

Page 2/2
PR.com Press Release Distribution Terms of Use